These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 144557)

  • 21. [Effect of antineoplastic agents on strains of human breast carcinoma and chorioepithelioma transplanted into nude mice].
    Revazova ES
    Vestn Akad Med Nauk SSSR; 1981; (9):79-83. PubMed ID: 7197438
    [No Abstract]   [Full Text] [Related]  

  • 22. Collateral sensitivity to N-(phosphonacetyl)-L-aspartic acid in a line of P388 leukemia cells selected for resistance to L-(alpha S, 5S)-alpha-amino-3- chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Ardalan B; Jayaram HN; Johnson RK
    Cancer Res; 1983 Apr; 43(4):1598-601. PubMed ID: 6831405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingomyelin potentiates chemotherapy of human cancer xenografts.
    Modrak DE; Lew W; Goldenberg DM; Blumenthal R
    Biochem Biophys Res Commun; 2000 Feb; 268(2):603-6. PubMed ID: 10679250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental chemotherapy of gastrointestinal carcinoma xenografts.
    Peckham MJ; Courtenay VD; Steel GG
    Cancer Treat Rev; 1979 Jun; 6 Suppl():43-50. PubMed ID: 498171
    [No Abstract]   [Full Text] [Related]  

  • 25. Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice.
    Fodstad O; Aass N; Pihl A
    Int J Cancer; 1980 Apr; 25(4):453-8. PubMed ID: 7372371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy of cell-line-derived human colon carcinomas in mice immunosuppressed with antithymocyte serum.
    Tibbetts LM; Chu MY; Hager JC; Dexter DL; Calabresi P
    Cancer; 1977 Nov; 40(5 Suppl):2651-9. PubMed ID: 303540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I trial of N-(phosphonacetyl)-L-aspartate.
    Erlichman C; Strong JM; Wiernik PH; McAvoy LM; Cohen MH; Levine AS; Hubbard SM; Chabner BA
    Cancer Res; 1979 Oct; 39(10):3992-5. PubMed ID: 157801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I trial of N-(Phosphonacetyl)-L-aspartic acid (PALA).
    Ervin TJ; Blum RH; Meshad MW; Kufe DW; Johnson RK; Canellos GP
    Cancer Treat Rep; 1980; 64(10-11):1067-71. PubMed ID: 7459892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical modulation: application of laboratory models to the clinic.
    Leyland-Jones B; O'Dwyer PJ
    Cancer Treat Rep; 1986 Jan; 70(1):219-29. PubMed ID: 3510736
    [No Abstract]   [Full Text] [Related]  

  • 30. Response of psoriasis to N-phosphonacetyl-L-aspartate.
    Earhart RH; DeConti RC; Rubin J; Ohnuma T
    Lancet; 1981 Jun; 1(8232):1257-8. PubMed ID: 6112581
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanisms of sensitivity or resistance of murine tumors to N-(phosphonacetyl)-L-aspartate (PALA).
    Jayaram HN; Cooney DA; Vistica DT; Kariya S; Johnson RK
    Cancer Treat Rep; 1979 Aug; 63(8):1291-302. PubMed ID: 476706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental chemotherapy of human carcinomas serially transplanted to nude mice--an evaluation of the Battelle Columbus Laboratories Protocol (author's transl)].
    Hanatani Y; Kubota T; Yamada Y; Tsuyuki K; Nakada M; Matsumoto S; Kumai K; Yoshino K; Ishibiki K; Abe O
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1114-20U. PubMed ID: 7229469
    [No Abstract]   [Full Text] [Related]  

  • 33. Diallyl disulfide suppresses the growth of human colon tumor cell xenografts in athymic nude mice.
    Sundaram SG; Milner JA
    J Nutr; 1996 May; 126(5):1355-61. PubMed ID: 8618131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
    Naoe Y; Inami M; Matsumoto S; Takagaki S; Fujiwara T; Yamazaki S; Kawamura I; Nishigaki F; Tsujimoto S; Manda T; Shimomura K
    Jpn J Cancer Res; 1998 Dec; 89(12):1306-17. PubMed ID: 10081492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial clinical study with N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with advanced cancer.
    Hart RD; Ohnuma T; Holland JF
    Cancer Treat Rep; 1980; 64(4-5):617-24. PubMed ID: 6448687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs.
    Fodstad O; Aass N; Pihl A
    Br J Cancer; 1980 May; 41(5):829-31. PubMed ID: 7426308
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of a new nitrosoureido water-soluble sugar, ecomustine or CY 233 (NSC 609224), on human xenografts.
    Dumont P; Atassi G; Roger P
    In Vivo; 1990; 4(1):61-4. PubMed ID: 2103843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I study of N-(phosphonacetyl)-L-aspartic acid (PALA).
    Kovach JS; Schutt AJ; Moertel CG; O'Connell MJ
    Cancer Treat Rep; 1979; 63(11-12):1909-12. PubMed ID: 526923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of bis-carbamoyloxymethyl derivatives of pyrroles and pyrrolizines against human tumor xenografts in nude mice.
    Anderson WK
    Cancer Res; 1982 Jun; 42(6):2168-70. PubMed ID: 6280852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of xenografts for the evaluation of tumor chemotherapy. Application to adjuvant chemotherapy].
    Duplan JF
    Bull Cancer; 1984; 71(4):292-6. PubMed ID: 6498344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.